No photo of Douglas Yee
Contact Expert

View Scopus Profile

Douglas Yee

1988 …2028
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 9 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Somatomedins Medicine & Life Sciences
Insulin-Like Growth Factor I Medicine & Life Sciences
IGF Type 1 Receptor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Somatomedin Receptors Medicine & Life Sciences
Insulin-Like Growth Factor Binding Proteins Medicine & Life Sciences
Insulin Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2028

Physical Activity Platform to Improve Bone Health in Cancer Survivors

Yee, D.

THRIVORS LLC

2/1/19 → 7/31/19

Project: Research project

Health
Neoplasms

Cancer Center Support Grant

Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, B. A., Peterson, L. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.

NIH NATIONAL CANCER INSTITUTE (NCI)

2/1/19 → 1/31/24

Project: Research project

Neoplasms

A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose ofCapecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive,Locally Advanced or Metastatic Breast Cancer Previously Treated

Yee, D.

ODONATE THERAPEUTICS, INC.

12/17/18 → 12/31/23

Project: Research project

Hormones
Breast Neoplasms
tesetaxel
Capecitabine

I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-dire

Yee, D.

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

9/8/17 → 8/31/19

Project: Research project

Breast Neoplasms

An open label, phase Ib, dose-escalation study evaluatin

Yee, D.

BOEHRINGER-INGELHEIM LIMITED

1/1/17 → 1/30/22

Project: Research project

Safety
BI 836845

Research Output 1988 2019

Erratum to: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)

I-SPY2 Investigators, Dec 1 2019, In : npj Breast Cancer. 5, 1, 2.

Research output: Contribution to journal › Comment/debate

Open Access
Axilla
Manuscripts
Clinical Trials
Breast Neoplasms
Jasminum

Green tea catechin extract supplementation does not influence circulating sex hormones and insulin-like growth factor axis proteins in a randomized controlled trial of postmenopausal women at high risk of breast cancer

Samavat, H., Wu, A. H., Ursin, G., Torkelson, C. J., Wang, R., Yu, M. C., Yee, D., Kurzer, M. S. & Yuan, J. M., Apr 1 2019, In : Journal of Nutrition. 149, 4, p. 619-627 9 p.

Research output: Contribution to journal › Article

Catechin
Gonadal Steroid Hormones
Somatomedins
Tea
Randomized Controlled Trials
4 Citations (Scopus)

40 years of IGF1: Anti-insulin-like growth factor therapy in breast cancer

Yee, D., Jul 1 2018, In : Journal of Molecular Endocrinology. 61, 1, p. T61-T68

Research output: Contribution to journal › Review article

Somatomedins
Clinical Trials
Breast Neoplasms
IGF Type 1 Receptor
Estrogen Receptors
2 Citations (Scopus)

Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment

Ungerleider, N. A., Rao, S. G., Shahbandi, A., Yee, D., Niu, T., Frey, W. D. & Jackson, J. G., Oct 1 2018, In : Breast Cancer Research. 20, 1, 115.

Research output: Contribution to journal › Article

Breast Neoplasms
Mutation
Survival
Hormones
Therapeutics

Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells

Yang, Y., Chan, J. Y., Temiz, N. A. & Yee, D., Dec 1 2018, In : Hormones and Cancer. 9, 6, p. 371-382 12 p.

Research output: Contribution to journal › Article

Tyrphostins
Insulin Receptor
Insulin-Like Growth Factor I
Insulin
Breast Neoplasms